HYPMY (Hypera) Sale Of Investment : $0 Mil (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Hypera Sale Of Investment?

Hypera's sale of investment for the three months ended in Sep. 2024 was $0 Mil. It means Hypera gained $0 Mil from selling investments. Hypera's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $0 Mil.

Compared with last quarter ($0 Mil in Jun. 2024 ), Hypera gained the same money from selling investments in Sep. 2024 ($0 Mil).

Hypera Sale Of Investment Historical Data

The historical data trend for Hypera's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Sale Of Investment Chart

Hypera Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Investment

Get a 7-Day Free Trial

0.95

17.91

Hypera Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Sale Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Hypera Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Hypera Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Hypera's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (OTCPK:HYPMY) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

HYPE3:Brazil

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.